Since E‐cadherin represses the first rate‐determining step in this process, the loss of E‐cadherin could provide elevated tolerance to centrosome amplification in cancers and serve as an adaptation mechanism for PACC division.[75] In addition, a significant enrichment of PPPR21A mutations has been observed in polyploid tumors. Here, CDH1 is linked to cancer.